Aflatoxins in Feed: Types, Metabolism, Health Consequences in Swine and Mitigation Strategies.
Roua Gabriela PopescuAndreea Luminița RădulescuSergiu Emil GeorgescuAnca DinischiotuPublished in: Toxins (2022)
Feeding farm animals with aflatoxin-contaminated feed can cause various severe toxic effects, leading to increased susceptibility to infectious diseases and increased mortality, weight loss, poor performance and reduced reproductive capability. Following ingestion of contaminated foodstuffs, aflatoxins are metabolized and biotransformed differently in animals. Swine metabolism is not effective in detoxifying and excreting aflatoxins, meaning the risk of aflatoxicosis is increased. Thus, it is of great importance to elucidate the metabolism and all metabolic pathways associated with this mycotoxin. The damage induced by AFB1 in cells and tissues consists of inhibition of cell proliferation, carcinogenicity, immunosuppression, mutagenicity, oxidative stress, lipid peroxidation and DNA damage, leading to pathological lesions in the liver, spleen, lymph node, kidney, uterus, heart, and lungs of swine. At present, it is a challenging task and of serious concern to completely remove aflatoxins and their metabolites from feedstuff; thus, the aim of this study was a literature review on the deleterious effects of aflatoxins on swine metabolism, as well as alternatives that contribute to the detoxification or amelioration of aflatoxin-induced effects in farm animal feed.
Keyphrases
- oxidative stress
- dna damage
- lymph node
- induced apoptosis
- infectious diseases
- weight loss
- cell proliferation
- diabetic rats
- heavy metals
- healthcare
- gene expression
- drinking water
- public health
- mental health
- heart failure
- dna repair
- climate change
- bariatric surgery
- squamous cell carcinoma
- type diabetes
- early onset
- early stage
- risk factors
- high glucose
- ischemia reperfusion injury
- palliative care
- cardiovascular disease
- risk assessment
- sentinel lymph node
- social media
- rectal cancer
- health information
- obese patients